← Back to headlines
Jacob Funds Invests in Cabaletta Bio and Prime Medicine
Jacob Funds has established positions in Cabaletta Bio (CABA) and Prime Medicine (PRME), focusing on next-generation gene therapy companies.
18 Feb, 13:34 — 18 Feb, 13:34
ℹOnly 1 source covers this story
